Cargando…
Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors
Epilepsy is a chronic neurological disorder that affects more than 50 million people worldwide. Despite a recent introduction of antiseizure drugs for the treatment of epileptic seizures, one‐third of these patients suffer from drug‐resistant epilepsy (DRE). The therapeutic target hypothesis is a ci...
Autores principales: | Fonseca‐Barriendos, Daniel, Frías‐Soria, Christian Lizette, Pérez‐Pérez, Daniel, Gómez‐López, Rosenda, Borroto Escuela, Dasiel O., Rocha, Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340308/ https://www.ncbi.nlm.nih.gov/pubmed/34542940 http://dx.doi.org/10.1002/epi4.12539 |
Ejemplares similares
-
Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
por: Rocha, Luisa, et al.
Publicado: (2020) -
Drug‐resistant epilepsy and the hypothesis of intrinsic severity: What about the high‐frequency oscillations?
por: Santana‐Gomez, Cesar E., et al.
Publicado: (2021) -
Introduction to the special issue “Redesigning the hypotheses for drug‐resistant epilepsy”
por: Rocha, Luisa
Publicado: (2022) -
Volume transmission and receptor-receptor interactions in heteroreceptor complexes: understanding the role of new concepts for brain communication
por: Fuxe, Kjell, et al.
Publicado: (2016) -
Can Allosteric Receptor-Protein Interactions in Receptor Complexes Be a Molecular Mechanism Involved in Cancer Immune Therapy?
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2019)